{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:27:52Z","timestamp":1780104472002,"version":"3.54.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Uterine fibroid embolization (UFE) is a minimally invasive alternative to surgery. Understanding utilization patterns and disparities in access is important to ensure that patients can explore all treatment options.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine trends in the use of UFE vs hysterectomy and myomectomy for uterine fibroid management, with an emphasis on sociodemographic and institutional disparities.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional analysis used data from the 2016 to 2022 National Inpatient Sample obtained from the Healthcare Cost and Utilization Project, a population-based, multicenter inpatient dataset representing hospitals across the US. Adult patients with a diagnosis of uterine fibroids who underwent hysterectomy, myomectomy, or UFE were identified using International Statistical Classification of Diseases, Tenth Revision, Clinical Modification<\/jats:italic> codes. Analysis was conducted in April 2025.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Patient age, race, ethnicity, insurance, income quartile, rurality, year of procedure, and hospital characteristics.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was undergoing UFE, modeled using multivariable logistic regression, with hysterectomy, myomectomy, or surgery overall as reference groups. The covariate reference categories were age younger than 30 years, White race, private insurance, 76th to 100th income percentile, central metropolitan residence, the year 2016, small hospitals, rural hospitals, and hospitals in the Pacific division. Results were reported as adjusted odds ratios (aORs) with 95% CIs.<\/jats:p><\/jats:sec>Results<\/jats:title>The sample encompassed 271\u202f885 encounters, including 199\u202f625 hysterectomies (73.4%), 62\u202f675 myomectomies (23.1%), and 9585 UFEs (3.5%). The median (IQR) patient age was 47 (43-52) years for those undergoing hysterectomy, 45 (40-49) years for those undergoing UFE, and 37 (33-41) years for those undergoing myomectomy. With regard to race and ethnicity, 105\u202f780 patients (38.9%) were African American, 16\u202f175 (5.9%) were Asian or Pacific Islander, 48\u202f810 (18.0%) were Hispanic, 1050 (0.4%) were Native American, 86\u202f425 were White (31.8%), and 13\u202f645 (5.0%) were other races. Increasing age was associated with lower odds of undergoing UFE vs hysterectomy, and higher odds of undergoing UFE vs myomectomy. African American patients were more likely to undergo UFE than hysterectomy (aOR, 1.64; 95% CI, 1.44-1.87), but less likely to undergo UFE than myomectomy (aOR, 0.84; 95% CI, 0.73-0.97). Hispanic patients were less likely to undergo UFE than both surgical procedures (aOR, 0.83; 95% CI, 0.71-0.97). Patients with Medicaid (aOR, 1.58; 95% CI, 1.41-1.77), self-pay (aOR, 1.97; 95% CI, 1.60-2.42), and no-charge (aOR, 1.97; 95% CI, 1.24-3.12) coverage had higher odds of undergoing UFE vs both surgical procedures. Among Medicare patients, UFE was more likely than myomectomy among those aged 30 to 49 years, but less likely among those aged 50 years and older. Those in the lowest income quartile (0-25th percentile) had greater odds of undergoing UFE vs myomectomy (aOR, 1.22; 95% CI, 1.04-1.43). Rural patients were less likely to undergo UFE than hysterectomy (aOR, 0.53; 95% CI, 0.34-0.83), whereas urban hospitals were more likely to perform UFE than both surgical procedures (aOR, 7.13; 95% CI, 3.43-14.80).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cross-sectional study, UFE was underutilized with significant disparities across socioeconomic factors. Further efforts are needed to equitably expand access to UFE across the country.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.32100","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:00:27Z","timestamp":1758034827000},"page":"e2532100","source":"Crossref","is-referenced-by-count":3,"title":["Disparities in Utilization of Uterine Fibroid Embolization"],"prefix":"10.1001","volume":"8","author":[{"given":"Tarig S.","family":"Elhakim","sequence":"first","affiliation":[{"name":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia"},{"name":"Department of Radiology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Smolinski-Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital, Boston"},{"name":"Department of Radiology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominie","family":"Miyasato","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladlena","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Mansur","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Puello","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad Del Norte, Atlantico, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Mercaldo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sophia","family":"McKenney","sequence":"additional","affiliation":[{"name":"Department of Radiology, New York\u2013Presbyterian Hospital\/Weill Cornell Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeeva P.","family":"Kalva","sequence":"additional","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital, Boston"},{"name":"Department of Radiology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dezube","sequence":"additional","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Daye","sequence":"additional","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital, Boston"},{"name":"Department of Radiology, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"issue":"1","key":"zoi250903r1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids.","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"zoi250903r2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-0037-1607264","article-title":"Uterine fibroids: burden and unmet medical need.","volume":"35","author":"Al-Hendy","year":"2017","journal-title":"Semin Reprod Med"},{"issue":"1","key":"zoi250903r4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/AOG.0000000000001160","article-title":"Association between patient characteristics and treatment procedure among patients with uterine leiomyomas.","volume":"127","author":"Borah","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi250903r5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa1914735","article-title":"Uterine-artery embolization or myomectomy for uterine fibroids.","volume":"383","author":"Manyonda","year":"2020","journal-title":"N Engl J Med"},{"issue":"2 Pt 1","key":"zoi250903r6","first-page":"387","article-title":"ACOG practice bulletin: alternatives to hysterectomy in the management of leiomyomas.","volume":"112","author":"American College of Obstetricians and Gynecologists","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"10","key":"zoi250903r7","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jvir.2020.04.039","article-title":"Utilization of endovascular and surgical treatments for symptomatic uterine leiomyomas: a population health perspective.","volume":"31","author":"Wang","year":"2020","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"zoi250903r8","doi-asserted-by":"publisher","first-page":"317.e1","DOI":"10.1016\/j.ajog.2011.03.016","article-title":"Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis.","volume":"205","author":"van der Kooij","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"zoi250903r10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jacr.2023.12.018","article-title":"Patient characteristics associated with embolization versus hysterectomy for uterine fibroids: a systematic review and meta-analysis.","volume":"21","author":"Srinivas","year":"2024","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"zoi250903r15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1214\/aos\/1176350273","article-title":"On simple adjustments to chi-square tests with sample survey data.","volume":"15","author":"Rao","year":"1987","journal-title":"Ann Stat"},{"issue":"3","key":"zoi250903r16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jvir.2016.11.008","article-title":"Specialty-specific values affecting the management of symptomatic uterine fibroids.","volume":"28","author":"Keller","year":"2017","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"zoi250903r17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue.","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi250903r18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.rssm.2005.06.001","article-title":"Racial differences in household wealth: beyond Black and White.","volume":"24","author":"Campbell","year":"2006","journal-title":"Res Soc Stratif Mobil"},{"issue":"10","key":"zoi250903r19","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jacr.2020.03.018","article-title":"Invasive procedural treatments for symptomatic uterine fibroids: a cost analysis.","volume":"17","author":"Cronan","year":"2020","journal-title":"J Am Coll Radiol"},{"issue":"6S","key":"zoi250903r20","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1016\/j.jacr.2024.02.022","article-title":"ACR Appropriateness Criteria\u00ae management of uterine fibroids: 2023 update.","volume":"21","author":"Makary","year":"2024","journal-title":"J Am Coll Radiol"},{"issue":"13","key":"zoi250903r21","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.3390\/jcm13133632","article-title":"Evolving referral patterns and management following implementation of a multidisciplinary fibroid center: a retrospective cohort study.","volume":"13","author":"Musselman","year":"2024","journal-title":"J Clin Med"},{"issue":"S1","key":"zoi250903r22","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1089\/pop.2017.0151","article-title":"Women with newly diagnosed uterine fibroids: treatment patterns and cost comparison for select treatment options.","volume":"21","author":"Bonafede","year":"2018","journal-title":"Popul Health Manag"},{"issue":"1","key":"zoi250903r23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00270-005-0369-5","article-title":"Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.","volume":"30","author":"Goldberg","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1105","key":"zoi250903r24","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190551","article-title":"Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature.","volume":"93","author":"Ludwig","year":"2020","journal-title":"Br J Radiol"},{"issue":"8","key":"zoi250903r25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jvir.2023.04.022","article-title":"Investigating the underutilization of uterine fibroid embolization by surveying practice preferences of obstetricians\/gynecologists.","volume":"34","author":"Kubiszewski","year":"2023","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"zoi250903r26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jvir.2022.11.017","article-title":"Uterine fibroid embolization or myomectomy: how much marketing is enough? comparative analysis of public search trends in Google and medical publications in PubMed.","volume":"34","author":"Jahangiri","year":"2023","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"zoi250903r27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263058","article-title":"The power of proximity: effects of a multidisciplinary fibroid clinic on inter-specialty perceptions and practice patterns.","volume":"17","author":"Keller","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"zoi250903r28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jvir.2009.01.029","article-title":"Management of uterine artery embolization for fibroids as an outpatient procedure.","volume":"20","author":"Pisco","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"zoi250903r3","unstructured":"American College of Obstetricians and Gynecologists. Management of symptomatic uterine leiomyomas: practice bulletin 228. June 2021. Accessed October 14, 2024. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-bulletin\/articles\/2021\/06\/management-of-symptomatic-uterine-leiomyomas"},{"key":"zoi250903r9","unstructured":"Gliklich? RE, Leavy? MB, Velentgas? P, . Identification of future research needs in the comparative management of uterine fibroid disease: a report on the priority-setting process, preliminary data analysis, and research plan. Agency for Healthcare Research and Quality. March 10, 2011. Accessed August 8, 2025. https:\/\/effectivehealthcare.ahrq.gov\/products\/uterine-fibroids-2010\/research"},{"key":"zoi250903r11","unstructured":"Healthcare Cost and Utilization Project. Overview of the National (Nationwide) Inpatient Sample (NIS). Accessed October 16, 2024. https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp"},{"key":"zoi250903r12","unstructured":"Healthcare Cost and Utilization Project. List of HCUP data partners for reference in publications. Accessed October 16, 2024. https:\/\/hcup-us.ahrq.gov\/db\/hcupdatapartners.jsp"},{"key":"zoi250903r13","unstructured":"Healthcare Cost and Utilization Project. Checklist for working with the NIS. Accessed October 16, 2024. https:\/\/hcup-us.ahrq.gov\/db\/nation\/nis\/nischecklist.jsp"},{"key":"zoi250903r14","unstructured":"National Center for Health Statistics. NCHS urban-rural classification scheme for counties. September 17, 2024. Accessed October 16, 2024. https:\/\/www.cdc.gov\/nchs\/data-analysis-tools\/urban-rural.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/nchs\/data_access\/urban_rural.htm"},{"key":"zoi250903r29","unstructured":"Healthcare Cost and Utilization Project. HCUP-US overview. Accessed October 16, 2024. https:\/\/hcup-us.ahrq.gov\/overview.jsp"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2839008\/elhakim_2025_oi_250903_1757431906.38927.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:00:28Z","timestamp":1758034828000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2839008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.32100","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}